Clinical Trial Update: A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 clinical trial evaluating a potential disease-modifying treatment for individuals at risk for or with early-onset Alzheimer's disease due t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Familial Alzheimer Disease

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: RECRUITING